Qing Li Peptide
Finnrick has tested 319 samples from Qing Li Peptide across 13 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| PT-141 | 6 | 31 Jul 2025 | 18 Mar 2026 | |||||
| Survodutide | 3 | 14 Jul 2025 | 3 Oct 2025 | |||||
| Cagrilintide | 4 | 9 Jul 2025 | 6 Mar 2026 | |||||
| CJC-1295 | 18 | 10 Jun 2025 | 13 May 2026 | |||||
| GHK-Cu | 34 | 10 Jul 2025 | 8 Jun 2026 | |||||
| Melanotan II | 7 | 18 Jul 2025 | 13 Mar 2026 | |||||
| Sermorelin | 5 | 18 Sep 2025 | 30 Dec 2025 | |||||
| BPC-157 | 30 | 11 Jun 2025 | 6 May 2026 | |||||
| Ipamorelin | 16 | 10 Jun 2025 | 27 May 2026 | |||||
| Retatrutide | 114 | 9 Jun 2025 | 8 Jun 2026 | |||||
| TB-500 | 18 | 29 Jun 2025 | 27 May 2026 | |||||
| Tesamorelin | 20 | 29 Jun 2025 | 28 Apr 2026 | |||||
| Tirzepatide | 43 | 3 Jul 2025 | 8 Jun 2026 | |||||
The Qing Li Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 59 overall satisfaction reports
People who submitted test requests to Finnrick gave Qing Li Peptide an average satisfaction rating of 4.6 out of 5 across 59 reports associated with samples received and tested by Finnrick.
Most recent Qing Li Peptide tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 8 Jun 2026 | Retatrutide | View | 10mg | 9.9mg | -1.0% | 99.30% | Apr 2, 2026 | No label / Gold crimp / Clear cap | Lab G | Public | |
| 8 Jun 2026 | Tirzepatide | View | 20mg | 24.1mg | +20.5% | 99.70% | Mar 2, 2026 | No label / Silver crimp / Violet cap | Lab G | Public | |
| 8 Jun 2026 | GHK-Cu | View | 50mg | 54.3mg | +8.6% | 99.90% | Oct 27, 2025 | No label / Silver crimp / White cap | Lab E | Public | |
| 5 Jun 2026 | Tirzepatide | View | 50mg | 48.7mg | -2.6% | 99.60% | TR 50 | No label / Blue crimp / Green cap | Lab E | Public | |
| 5 Jun 2026 | Retatrutide | View | 40mg | 38.7mg | -3.3% | 99.90% | Mar 2, 2026 | White label / Silver crimp / Clear Red cap | Lab E | Public | |
| 2 Jun 2026 | GHK-Cu | View | 50mg | 46.4mg | -7.2% | 99.90% | March 6, 2026 | No label / Silver crimp / Blue cap | Lab E | Public | |
| 27 May 2026 | Retatrutide | View | 10mg | 12.4mg | +24.0% | 99.90% | Dec 2, 2025 | No label / Silver crimp / Clear Yellow cap | Lab E | Public | |
Corrections
- 25 Jul 2025:
- Qing Li Peptides print a manufacturing date on their kit boxes. We consider this an equivalent to a batch ID, as it is clearly printed on the packaging and available for the public. When samples are submitted by the public, this identifier was not always collected, affecting test scores. This data may be collected in the future, resulting in an updated test score, and Finnrick Rating.
About Qing Li Peptide Test Results From Finnrick
Qing Li Peptide is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 13 products and 319 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Qing Li Peptide Testing Activity & Score Summary
In the past 30 days, Finnrick has published 10 new test results for Qing Li Peptide, and 34 in the past three months. The overall dataset includes 319 tested samples with an average score of 7.1/10 across all products.
Across 318 identity-tested samples, 98% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.7%. Approximately 87% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (114 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 2.8 to 10.0 (average 7.7/10), suggesting significant batch-to-batch differences.
- GHK-Cu (34 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 4.7 to 10.0 (average 7.9/10), suggesting significant batch-to-batch differences.
- Tirzepatide (43 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 2.9 to 10.0 (average 7.0/10), suggesting significant batch-to-batch differences.